On Monday, Japanese pharma company ONO Pharmaceutical agreed to acquire Deciphera Pharmaceuticals Inc ( DCPH ) for $25.60 per share in cash, for a total equity value of $2.4 billion.  Deciphera brings specialized research and development capabilities in kinase drug discovery, well-established commercial and sales platforms in the United States and Europe, and global clinical development capabilities.  In addition to QINLOCK – Deciphera’s switch-control inhibitor...

LONDON, April 29 (Reuters) - Some 19% of votes cast at Ocado's ( OCDGF ) annual shareholder meeting on Monday opposed the online grocer and technology group's proposed new pay policy that could see boss Tim Steiner pick up a bonus share award of up to 15 million pounds ($19 million). The FTSE 100 group, which sells its robotic technology...

12:05 PM EDT, 04/29/2024 (MT Newswires) -- Wall Street's major market indexes were all up in late-morning trading as investors prepared for a Federal Open Market Committee meeting this week. Banco Bilbao Vizcaya Argentaria ( BBVA ) reported Q1 adjusted earnings Monday of 0.37 euro ($0.40) per share, up from 0.30 euro per share a year earlier. Two analysts polled...

12:16 PM EDT, 04/29/2024 (MT Newswires) -- Deciphera Pharmaceuticals ( DCPH ) on Monday agreed to be acquired by Japan-based ONO Pharmaceutical through a tender offer in a deal worth roughly $2.4 billion. Under the terms, investors of the US biopharmaceutical company will receive $25.60 per share in cash, representing a premium of about 75% to its closing price on...